Also distributed through HRC
Wharton’s Jelly Biologics
Wharton’s-jelly-derived connective-tissue allografts for structural support. 361 HCT/P, minimally manipulated, intended for homologous use only. Composition and specifications are confirmed by your dedicated representative.
Product line
Available through a dedicated representative.
Specifications, composition, and pricing for this product line are not surfaced publicly and are confirmed per credentialed provider directly by your representative.
Regulatory framing
361 HCT/P, homologous use only.
Wharton’s jelly is the gelatinous connective tissue within the umbilical cord. Products distributed under this brand family are minimally manipulated human cell, tissue, and cellular and tissue-based products (HCT/Ps) regulated solely under Section 361 of the Public Health Service Act, intended only for homologous use consistent with each product’s manufacturer labeling and the provider’s licensed scope of practice.
Provider accounts
Apply once. Order anytime.
HRC distributes exclusively to licensed providers. A dedicated representative will verify your account and confirm pricing within one business day.